BIOMAT Database Logo BIOMAT Database Logo

[Pharmacokinetics of rifampicin in patients with pulmonary tuberculosis]. 1977

V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
[Rifampicin pharmacokinetics in patients with destructive pulmonary tuberculosis].
December 1988, Vrachebnoe delo,
V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
[Rifampicin pharmacokinetics in patients with pulmonary tuberculosis with concomitant helminthiasis].
April 1989, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
Population Pharmacokinetics of Rifampicin in Chinese Patients With Pulmonary Tuberculosis.
May 2016, Journal of clinical pharmacology,
V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
[Pharmacokinetics of rifampicin administered intravenously to pulmonary tuberculosis patients].
March 1987, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
The Population Pharmacokinetics of Rifampicin in Japanese Pulmonary Tuberculosis Patients.
May 2020, Drug research,
V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
Studies on pharmacokinetics of rifampicin in the body of patients with pulmonary tuberculosis.
January 1979, Arzneimittel-Forschung,
V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis.
January 2021, Frontiers in pharmacology,
V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
Pharmacokinetics of standard dose regimens of rifampicin in patients with pulmonary tuberculosis in Pakistan.
June 2012, Scandinavian journal of infectious diseases,
V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis.
February 2013, Journal of clinical pharmacy and therapeutics,
V D Gol'dshteĭn, and R A Ioffe, and V L Kriukov
[Rifampicin metabolism in patients with pulmonary tuberculosis].
November 1975, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
Copied contents to your clipboard!